These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 9756856

  • 1. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.
    Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M.
    J Biol Chem; 1998 Oct 09; 273(41):26292-4. PubMed ID: 9756856
    [Abstract] [Full Text] [Related]

  • 2. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA, Harper JD, Lansbury PT.
    Biochemistry; 2000 Mar 14; 39(10):2552-63. PubMed ID: 10704204
    [Abstract] [Full Text] [Related]

  • 3. Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons.
    Saha AR, Hill J, Utton MA, Asuni AA, Ackerley S, Grierson AJ, Miller CC, Davies AM, Buchman VL, Anderton BH, Hanger DP.
    J Cell Sci; 2004 Mar 01; 117(Pt 7):1017-24. PubMed ID: 14996933
    [Abstract] [Full Text] [Related]

  • 4. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.
    Li J, Uversky VN, Fink AL.
    Biochemistry; 2001 Sep 25; 40(38):11604-13. PubMed ID: 11560511
    [Abstract] [Full Text] [Related]

  • 5. Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies.
    Higuchi S, Arai H, Matsushita S, Matsui T, Kimpara T, Takeda A, Shirakura K.
    Exp Neurol; 1998 Sep 25; 153(1):164-6. PubMed ID: 9743579
    [Abstract] [Full Text] [Related]

  • 6. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.
    Mezey E, Dehejia AM, Harta G, Tresser N, Suchy SF, Nussbaum RL, Brownstein MJ, Polymeropoulos MH.
    Mol Psychiatry; 1998 Nov 25; 3(6):493-9. PubMed ID: 9857974
    [Abstract] [Full Text] [Related]

  • 7. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein.
    Choi W, Zibaee S, Jakes R, Serpell LC, Davletov B, Crowther RA, Goedert M.
    FEBS Lett; 2004 Oct 22; 576(3):363-8. PubMed ID: 15498564
    [Abstract] [Full Text] [Related]

  • 8. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
    Jo E, Fuller N, Rand RP, St George-Hyslop P, Fraser PE.
    J Mol Biol; 2002 Jan 25; 315(4):799-807. PubMed ID: 11812148
    [Abstract] [Full Text] [Related]

  • 9. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
    Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T.
    Am J Pathol; 1998 Apr 25; 152(4):879-84. PubMed ID: 9546347
    [Abstract] [Full Text] [Related]

  • 10. Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain.
    Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, Schindzielorz A, Okochi M, Leimer U, van Der Putten H, Probst A, Kremmer E, Kretzschmar HA, Haass C.
    J Neurosci; 2000 Sep 01; 20(17):6365-73. PubMed ID: 10964942
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.
    Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M.
    Proc Natl Acad Sci U S A; 1998 May 26; 95(11):6469-73. PubMed ID: 9600990
    [Abstract] [Full Text] [Related]

  • 13. alpha-Synuclein filaments bind the transcriptional regulator HMGB-1.
    Lindersson EK, Højrup P, Gai WP, Locker D, Martin D, Jensen PH.
    Neuroreport; 2004 Dec 22; 15(18):2735-9. PubMed ID: 15597044
    [Abstract] [Full Text] [Related]

  • 14. Alpha-synuclein and Parkinson's disease.
    Golbe LI.
    Adv Neurol; 2003 Dec 22; 91():165-74. PubMed ID: 12442675
    [No Abstract] [Full Text] [Related]

  • 15. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT.
    J Neuropathol Exp Neurol; 1998 Apr 22; 57(4):334-7. PubMed ID: 9600226
    [Abstract] [Full Text] [Related]

  • 16. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
    Liani E, Eyal A, Avraham E, Shemer R, Szargel R, Berg D, Bornemann A, Riess O, Ross CA, Rott R, Engelender S.
    Proc Natl Acad Sci U S A; 2004 Apr 13; 101(15):5500-5. PubMed ID: 15064394
    [Abstract] [Full Text] [Related]

  • 17. Caught in the act: alpha-synuclein is the culprit in Parkinson's disease.
    Eriksen JL, Dawson TM, Dickson DW, Petrucelli L.
    Neuron; 2003 Oct 30; 40(3):453-6. PubMed ID: 14642269
    [Abstract] [Full Text] [Related]

  • 18. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA, Harper JD, Lansbury PT.
    Nat Med; 1998 Nov 30; 4(11):1318-20. PubMed ID: 9809558
    [Abstract] [Full Text] [Related]

  • 19. Neuropathology in mice expressing human alpha-synuclein.
    van der Putten H, Wiederhold KH, Probst A, Barbieri S, Mistl C, Danner S, Kauffmann S, Hofele K, Spooren WP, Ruegg MA, Lin S, Caroni P, Sommer B, Tolnay M, Bilbe G.
    J Neurosci; 2000 Aug 15; 20(16):6021-9. PubMed ID: 10934251
    [Abstract] [Full Text] [Related]

  • 20. alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease.
    Wood SJ, Wypych J, Steavenson S, Louis JC, Citron M, Biere AL.
    J Biol Chem; 1999 Jul 09; 274(28):19509-12. PubMed ID: 10391881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.